167 related articles for article (PubMed ID: 25250508)
1. Importance of the pharmacological profile of the bound ligand in enrichment on nuclear receptors: toward the use of experimentally validated decoy ligands.
Lagarde N; Zagury JF; Montes M
J Chem Inf Model; 2014 Oct; 54(10):2915-44. PubMed ID: 25250508
[TBL] [Abstract][Full Text] [Related]
2. Structure-based virtual screening of the nociceptin receptor: hybrid docking and shape-based approaches for improved hit identification.
Daga PR; Polgar WE; Zaveri NT
J Chem Inf Model; 2014 Oct; 54(10):2732-43. PubMed ID: 25148595
[TBL] [Abstract][Full Text] [Related]
3. Toward a benchmarking data set able to evaluate ligand- and structure-based virtual screening using public HTS data.
Lindh M; Svensson F; Schaal W; Zhang J; Sköld C; Brandt P; Karlén A
J Chem Inf Model; 2015 Feb; 55(2):343-53. PubMed ID: 25564966
[TBL] [Abstract][Full Text] [Related]
4. Structure-based virtual screening of MT2 melatonin receptor: influence of template choice and structural refinement.
Pala D; Beuming T; Sherman W; Lodola A; Rivara S; Mor M
J Chem Inf Model; 2013 Apr; 53(4):821-35. PubMed ID: 23541165
[TBL] [Abstract][Full Text] [Related]
5. New strategy for receptor-based pharmacophore query construction: a case study for 5-HT₇ receptor ligands.
Kurczab R; Bojarski AJ
J Chem Inf Model; 2013 Dec; 53(12):3233-43. PubMed ID: 24245803
[TBL] [Abstract][Full Text] [Related]
6. Comparative study on the use of docking and Bayesian categorization to predict ligand binding to nicotinic acetylcholine receptors (nAChRs) subtypes.
Kombo DC; Bencherif M
J Chem Inf Model; 2013 Dec; 53(12):3212-22. PubMed ID: 24328365
[TBL] [Abstract][Full Text] [Related]
7. Ligand efficiency-based support vector regression models for predicting bioactivities of ligands to drug target proteins.
Sugaya N
J Chem Inf Model; 2014 Oct; 54(10):2751-63. PubMed ID: 25220713
[TBL] [Abstract][Full Text] [Related]
8. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
Zhang X; Wong SE; Lightstone FC
J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
[TBL] [Abstract][Full Text] [Related]
9. Discovery of new non-steroidal farnesoid X receptor modulators through 3D shape similarity search and structure-based virtual screening.
Wang L; Si P; Sheng Y; Chen Y; Wan P; Shen X; Tang Y; Chen L; Li W
Chem Biol Drug Des; 2015 Apr; 85(4):481-7. PubMed ID: 25228339
[TBL] [Abstract][Full Text] [Related]
10. Molecular dynamics-based virtual screening: accelerating the drug discovery process by high-performance computing.
Ge H; Wang Y; Li C; Chen N; Xie Y; Xu M; He Y; Gu X; Wu R; Gu Q; Zeng L; Xu J
J Chem Inf Model; 2013 Oct; 53(10):2757-64. PubMed ID: 24001302
[TBL] [Abstract][Full Text] [Related]
11. Ligand aligning method for molecular docking: alignment of property-weighted vectors.
Joung JY; Nam KY; Cho KH; No KT
J Chem Inf Model; 2012 Apr; 52(4):984-95. PubMed ID: 22471323
[TBL] [Abstract][Full Text] [Related]
12. Pharmacophore based virtual screening, molecular docking studies to design potent heat shock protein 90 inhibitors.
Sakkiah S; Thangapandian S; John S; Lee KW
Eur J Med Chem; 2011 Jul; 46(7):2937-47. PubMed ID: 21531051
[TBL] [Abstract][Full Text] [Related]
13. Molecular topology applied to the discovery of 1-benzyl-2-(3-fluorophenyl)-4-hydroxy-3-(3-phenylpropanoyl)-2H-pyrrole-5-one as a non-ligand-binding-pocket antiandrogen.
Caboni L; Gálvez-Llompart M; Gálvez J; Blanco F; Rubio-Martinez J; Fayne D; Lloyd DG
J Chem Inf Model; 2014 Oct; 54(10):2953-66. PubMed ID: 25233256
[TBL] [Abstract][Full Text] [Related]
14. QSAR classification model for antibacterial compounds and its use in virtual screening.
Singh N; Chaudhury S; Liu R; AbdulHameed MD; Tawa G; Wallqvist A
J Chem Inf Model; 2012 Oct; 52(10):2559-69. PubMed ID: 23013546
[TBL] [Abstract][Full Text] [Related]
15. Recognizing pitfalls in virtual screening: a critical review.
Scior T; Bender A; Tresadern G; Medina-Franco JL; Martínez-Mayorga K; Langer T; Cuanalo-Contreras K; Agrafiotis DK
J Chem Inf Model; 2012 Apr; 52(4):867-81. PubMed ID: 22435959
[TBL] [Abstract][Full Text] [Related]
16. Molecular modeling of the 3D structure of 5-HT(1A)R: discovery of novel 5-HT(1A)R agonists via dynamic pharmacophore-based virtual screening.
Xu L; Zhou S; Yu K; Gao B; Jiang H; Zhen X; Fu W
J Chem Inf Model; 2013 Dec; 53(12):3202-11. PubMed ID: 24245825
[TBL] [Abstract][Full Text] [Related]
17. Novel inhibitor discovery through virtual screening against multiple protein conformations generated via ligand-directed modeling: a maternal embryonic leucine zipper kinase example.
Mahasenan KV; Li C
J Chem Inf Model; 2012 May; 52(5):1345-55. PubMed ID: 22540736
[TBL] [Abstract][Full Text] [Related]
18. Benchmark data sets for structure-based computational target prediction.
Schomburg KT; Rarey M
J Chem Inf Model; 2014 Aug; 54(8):2261-74. PubMed ID: 25084060
[TBL] [Abstract][Full Text] [Related]
19. Beware of machine learning-based scoring functions-on the danger of developing black boxes.
Gabel J; Desaphy J; Rognan D
J Chem Inf Model; 2014 Oct; 54(10):2807-15. PubMed ID: 25207678
[TBL] [Abstract][Full Text] [Related]
20. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
Hoffer L; Renaud JP; Horvath D
J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
